SMALL CELL
Limited:
Extensive:
NON-SMALL CELL
Stage I:
-
SWOG E5597: Phase III Chemoprevention Trial of
Selenium Supplementation in Persons with Resected Stage
I Non-Small Cell Lung Cancer.
-
SWOG 0429: A Pilot (Phase I) Study of Weekly
Docetaxel and Cetuximab Chemoradiation for Poor Risk
Stage III Non-Small Cell Lung Cancer
-
CTSU C140503: A Phase III Randomized Trial Of
Lobectomy Versus Sublobar Resection For Small Peripheral
Non-Small Cell Lung Cancer
Selected:
-
CTSU E1505:
A Phase III Randomized Trial of Adjuvant Chemotherapy With or
Without Bevacizumab for Completely Resected Stage IB-IIIA
Non-Small Cell Lung Cancer (NSCLC)
Extensive:
-
SWOG 0636:
A Phase II Trial of the Combination of OSI-774 (Erlotinib;
NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in
Never-Smokers with Stage IIIB and IV Primary NSCLC
Adenocarcinomas
- PSOC 6137:
A Phase II Study if Intermittent Gleevec (Imatinib mesylate) and
Weekly Paclitaxel in Patients Aged 70 or Older with Advanced
Non-small Cell Lung Cancer
MESOTHELIOMA
BRONCHIOLOALVEOLAR:
-
SWOG 0526: Phase II Trial of Pemetrexed in Patients
with Selected Stage IIIB and IV Bronchioloalveolar
Carcinoma (BAC)
-
SWOG 0635: A Phase II Trial of the Combination
of OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (Rhumab
VEGF; NSC-704865) in Stage IIIB and IV
Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma
with BAC Features
For more information on the above clinical
trials:
Cheryl Patz, RN, OCN, CCRC, 360.715.4133
Return to previous page
|